Product Main

Quick Details

Purity: 99% min
Model Number: CAS: 317318-70-0
Brand Name: NJBN
Grade Standard:
Type: Central Nervous System Agents,
Place of Origin: China (Mainland)
MF: C25H34O3
Other Names: finaplix
CAS No.: 472-61-546

Specifications

317318-70-0 SARMS Bodybuilding Pharmaceutical GW-501516 Cardarine

 

 

--- Basic Info ---

 

  • GW-501516
  • Alias : Cardarine  
  • Synonyms : 2-(4-((2-(4-(TRIFLUOROMETHYL)PHENYL)-5-METHYLTHIAZOL-4-YL)METHYLTHIO)-2-METHYLPHENOXY)ACETIC ACID ; 2-[2-Methyl-4-[[[4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]methyl]thio]phenoxy]acetic Acid ; Methyl-methyl-trifluoromethylphenyl -thiazolyl-methylsulfanyl-phenoxy-acetic Acid ; 2-(4-((2-(4-(trifluoromethyl)phenyl)-4-methylthiazol-5-yl)methylthio)-2-methylphenoxy)acetic acid ; GW 1516 ; 2-(2-methyl-4-((5-methyl-2-(4-(trifluoromethyl)phenyl)thiazol-4-yl)methylthio)phenoxy)acetic acid ; GW501516, Free Acid ; GSK-516 ; Antineoplastic ; SARMs ( Selective androgen receptor modulator )
  • CAS : 317318-70-0
  • Assay : > 99%
  • MF : C21H18F3NO3S2
  • MW : 453.5
  • MP : 134-136°C
  • Appearance : White powder
  • Product Categories : Selective Androgen Receptor ; Intermediates & Fine Chemicals ; Pharmaceuticals ; Sulfur & Selenium Compounds ; kl ; Inhibitor 
  • Usage : It had been investigated as a potential treatment for obesity , diabetes , dyslipidemia and cardiovascular disease . GW501516 could be used by athletes as an ergogenic performance enhancing drug .

--- Selective Androgen Receptor Description ---

 

  • GW 501516 ( Cardarine ) is one of the most versatile performance enhancers one will ever come across .

 

  • Whether you are looking to drastically increase endurance , melt fat, cut or recomp, GW will truly shine . In this article , I am going to touch on the many ways and reason to incorporate GW into every cycle that you run . There is a place for GW in every cycle , regardless of the desired goal . It can only add extra benefits that will further enhance the chances of accomplishing goals and maximizing gains .

 

  • GW-501516 is a unique medication officially classified as a PPAR receptor agonist ( PPAR-RA ) . Research for this medication began in 1992 in a conjoined effort between GlaxoSmithKline ( GSK ) and Ligand Pharmaceuticals. Research into this product was set forth in an effort to provide treatment for various cardiovascular diseases , as well as diabetes , obesity and other conditions . It was soon discovered that the PPAR-RA was highly effective at enhancing endurance , but it was also shown to carry a high potential cost. It was discovered that GW-501516 increased the chances of cancer significantly, and as a result, GSK dropped all further research . However , the studies that produced cancerous results used doses of GW-501516 that were 500 to even 1000 times the amount that a human being would take . If cancer is a risk with standard dosing is unknown .

SARMs:


MK-2866 CAS:1202044-20-9, 841205-47-8
LGD-4033 CAS:1165910-22-4
GW-501516 CAS:317318-70-0
MK-677 CAS:159752-10-0
GTX-007/S4/Andarine CAS:401900-40-1
SR-9009 CAS:1379686-30-2
RAD-140 CAS:118237-47-0
YK-11 CAS:431579-34-9
AICAR CAS:2627-69-2

GW0742 CAS:317318-84-6
GS5816 CAS:1377049-84-7